关于美国OTC|国内主体直接申请上市的流程和注意事项

Group 1 - The core viewpoint of the article discusses the process and considerations for domestic companies applying directly for OTC listing in the U.S., highlighting the case of HNIT, which plans to list on OTCQB by March 2025 to finance its global health industry expansion [2] - The costs associated with the OTC application include U.S. legal fees, PCAOB audit fees, financial accounting fees during the audit period, EDGAR printer fees, and OTC Market application fees [3] - The article outlines that the total estimated cost for the OTC listing process is approximately $400,000 [5] Group 2 - Companies must prepare existing financial statements (balance sheet, income statement, cash flow statement) for at least six months, and can still list even if they are currently operating at a loss, as future growth potential is the main focus [5] - The listing process involves several steps, including financial accounting, audit report issuance, drafting and submitting the prospectus, responding to SEC inquiries, Form 211 submission, OTC approval, and finally, listing [5] - The expected timeline for the listing process is 9 to 12 months, with 1 to 5 months for pre-submission, 6 to 9 months for F-1 effectiveness, and subsequent listing [5]